A systems approach to the detection of familial chylomicronaemia syndrome (FCS) in adults Akcea Therapeutics UK Ltd February 2020 Best-practice recommendations to support the optimisation of managing patients with familial chylomicronaemia syndrome
Familial chylomicronaemia syndrome (FCS) in adults—implementing a systems approach to detection and management Akcea Therapeutics UK Ltd January 2020 Best-practice recommendations to support the optimisation of managing patients with familial chylomicronaemia syndrome
Switching from subcutaneous trastuzumab to intravenous biosimilar trastuzumab (Herzuma®▼): experience in a Scottish health board Napp Pharmaceuticals Limited October 2019 Case study on switching patients with breast cancer from originator to biosimilar trastuzumab
